Company: SWKH
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001628280-25-040420
Chunk: 92

Company: SWK Holdings Corp
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 92
---
ight, LLC105,048 $7.62 — — MolecuLight, Inc.394,322 C$0.84 — — — Revenue RecognizedAssetsQ2 2025Year-to-DateTotal finance receivables, gross$246,430 $8,543 $19,255 Total marketable investments603 — — Total fair value of warrant assets4,612 — — Total$251,645 $8,543 $19,255 

 (1)US royalty was paid off continues to receive insignificant royalties on international sales.(2)Investment considered partially impaired.(3)Investment on non-accrual.(4)Flowonix Medical assets were sold to a medical device company in a prior period. In exchange for releasing its lien, SWK received cash at close and is expected to receive royalties on sales of two products.(5)AOTI warrants exercised and converted to shares.(6)Royalties sold as of June 30, 2025(7)Investment was paid off during the six months ended June 30, 2025(8)Elutia common stock received as part of amendment to term loan.

Unless otherwise specified, our senior secured debt assets generally are repaid by a revenue interest that is charged on a company’s quarterly net sales and royalties.

28

Critical Accounting Policies and Estimates 

Our critical accounting policies and estimates are described in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report. We believe there have been no new critical accounting policies or material changes to our existing critical accounting policies and estimates during the six months ended June 30, 2025, compared to those discussed in our Annual Report.

Recent Accounting Pronouncements

Refer to Part I. Financial Information, Item 1. Financial Statements, Note 1 of the notes to the unaudited condensed consolidated financial statements for a listing of recent accounting pronouncements and their potential impact to our consolidated financial statements.

Comparison of the three months ended June 30, 2025 and 2024 (in millions)

Three Months EndedJune 30,20252024Change $Revenues$10.1 $10.8 $(0.7)Provision for credit losses0.8 4.1 (3.3)Loss on impairment of intangible assets— 5.8 (5.